Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : LLY crawled date : 2021 - 08 - 03 save search
Amgen Reports Second Quarter 2021 Financial Results
Published: 2021-08-03 (Crawled : 23:00) - biospace.com/
LLY | News | $735.9 0.63% 180K
|
Health Technology
|
| O: -0.75%
H: 5.97%
C: 4.59%
XNCR | $18.21 510K
|
Health Technology
|
| O: 0.55%
H: 1.32%
C: 1.03%
REGN | News | $910.82 1.18% 21K
|
Health Technology
|
| O: -0.05%
H: 1.86%
C: 1.67%
BGNE | $137.95 5.35% 14K
|
Health Technology
|
| O: 0.21%
H: 4.53%
C: 4.06%
AMGN | News | $273.97 0.76% 69K
|
Health Technology
|
| O: 0.4%
H: 1.51%
C: 1.38%
financial results results report
Eli Lilly in the News: COVID-19, Q2 and Ad Drama
Published: 2021-08-03 (Crawled : 15:00) - biospace.com/
LLY | News | $735.9 0.63% 180K
|
Health Technology
|
| O: -0.75%
H: 5.97%
C: 4.59%
covid covid-19
Iterative Scopes Raises $30 Million Series A Financing to Advance AI-Driven Precision Medicine for Gastroenterology
Published: 2021-08-03 (Crawled : 13:00) - biospace.com/
JNJ | News | $148.88 -0.16% 940K
|
Health Technology
|
| O: 0.27%
H: 1.02%
C: 0.96%
LLY | News | $735.9 0.63% 180K
|
Health Technology
|
| O: -0.75%
H: 5.97%
C: 4.59%
Gennao Bio Appoints Dale L. Ludwig, Ph.D., as Chief Scientific Officer
Published: 2021-08-03 (Crawled : 12:00) - biospace.com/
LLY | News | $735.9 0.63% 180K
|
Health Technology
|
| O: -0.75%
H: 5.97%
C: 4.59%
Vanda Pharmaceuticals Closes Enrollment In The ODYSSEY Study Comparing Tradipitant And Placebo In Hospitalized COVID-19 Pneumonia Patients
Published: 2021-08-03 (Crawled : 12:00) - biospace.com/
LLY | News | $735.9 0.63% 180K
|
Health Technology
|
| O: -0.75%
H: 5.97%
C: 4.59%
VNDA | $4.8 -6.07% -6.46% 15K
|
Health Technology
|
| O: -1.6%
H: 1.86%
C: 1.68%
covid enroll
Lilly Delivers Strong Second-Quarter 2021 Financial Results, Updates 2021 Financial Guidance
Published: 2021-08-03 (Crawled : 12:00) - biospace.com/
ABCL | $4.01 78K
|
|
| O: 1.14%
H: 0.0%
C: -1.56%
LLY | News | $735.9 0.63% 180K
|
Health Technology
|
| O: -0.75%
H: 5.97%
C: 4.59%
RIGL | $1.15 1.77% 49K
|
Health Technology
|
| O: 0.5%
H: 0.5%
C: -6.44%
DTIL | $9.68 1.7K
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: -1.21%
MRUS | $41.51 2.62% 20K
|
Health Technology
|
| O: 0.9%
H: 1.45%
C: 0.67%
financial results results liver
Lilly and Incyte's baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation
Published: 2021-08-03 (Crawled : 10:00) - prnewswire.com
LLY | News | $735.9 0.63% 180K
|
Health Technology
|
| O: -0.75%
H: 5.97%
C: 4.59%
INCY | $51.98 0.12% 72K
|
Health Technology
|
| O: -0.7%
H: 0.31%
C: 0.04%
covid baricitinib covid-19
First half of 2021: Boehringer Ingelheim makes fundamental progress in research and development
Published: 2021-08-03 (Crawled : 09:00) - biospace.com/
LLY | News | $735.9 0.63% 180K
|
Health Technology
|
| O: -0.75%
H: 5.97%
C: 4.59%
research
Gainers vs Losers
| 81% | 19% |
Top 10 Gainers
MTTR | News M | $4.625 165.81% 5.5M
|
AGBA | $2.615 109.2% 14M
|
Finance
EDBL | News | $7.37 96.01% 650K
|
PALI | $7.64 54.97% 14M
|
Manufacturing
OPRT | News | $3.19 41.78% 3M
|
Finance
PEGY | $0.0629 37.34% 110M
|
Manufacturing
MLEC | $1.87 33.57% 1.6M
|
n/a
ATGL | $3.66 27.97% 150K
|
SMFL | $5.35 22.99% 11M
|
Manufacturing
KULR | $0.5446 22.0% 6.8M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.